Chiron Real Estate (XRN) Q3 2026 earnings summary

Executive summary

• Strategic shift toward seniors housing; more than $430M of proprietary seniors housing investments closed YTD, with execution and disciplined investment emphasized.

• Outpatient medical portfolio monetization remains a priority, with a broker engaged and encouraging buyer interest; proceeds are expected to support seniors housing investment.

• At September 30, gross investments were 81% healthcare facilities, 17% SHOP communities and 2% joint ventures and other investments.

Financial highlights

• Q3 revenue was $40.335M vs. $37.229M YoY; net loss attributable to common stockholders was $8.863M, or $0.67 per diluted share.

• Q3 Nareit-defined FFO was $0.50 per share and unit vs. $1.00 YoY; Core FFO was $0.75 vs. $1.12. Nine-month Core FFO was $2.90 vs. $3.37.

• Nine-month revenue was $118.146M vs. $109.816M; net income of $68.2M included a $71.622M gain on property sales.

• Q3 Adjusted EBITDAre was $23.0M vs. $25.7M YoY; nine-month Adjusted EBITDAre was $74.3M vs. $76.0M.

• Outpatient medical same-property Cash NOI increased 1.6% YoY; Q3 cash G&A was $5.3M, including $1.2M of cash severance and transition costs.

Outlook and guidance

• The Riviera is expected to achieve yield-on-cost above 7% in H2 2028; The Pinnacle is expected to exceed 7% stabilized yield-on-cost in 2029.

• SHOP is expected to contribute more as communities stabilize and occupancy rises; growth plans include acquisitions, development JVs and operator partnerships.

• Net debt to EBITDA may fluctuate as The Riviera and The Pinnacle lease up; near-term funding may come from operating cash flow, debt and equity, dispositions and recapitalizations.

• Management hopes to update on outpatient medical dispositions by the next earnings call; leasing incentives are intended to taper as occupancy grows.